Somatic Mutations in High Grade Endometrial Cancers
TCGA: Integrated Genomic Characterization of Endometrial Carcinoma - Douglas Levine
Molecular Classification of Endometrial Cancer and Targeted Therapy Considerations
ENDOMETRIAL CARCINOMA: Risk factors, Etiopathogenesis, Morphology & Clinical features
Endometrial Carcinoma Part I (Female Genital Tract)
MPCCC Cancer Seminars: A/Prof Yoland Antill
Dr. Dizon on PTEN Mutations in Endometrial Cancer
Loss-of-heterozygosity as a biomarker for poor outcomes in endometrial cancer
Dr. Mutch on Biomarkers in Endometrial Cancer
Molecular classification and adjuvant treatment in endometrial cancer
Not All Uterine Cancer is the Same: What to Know About Rare Uterine Cancers
CTNNB1 Mutation and the Wnt Pathway in Endometrial Cancer
Introduction: Molecular Testing in Ovarian Cancer
BRCA Mutations and Lynch Syndrome
Report Back from SGO: What’s the Latest in Uterine Cancer?
Hereditary Endometrial Cancer
BRCA 1/2 and Gyn Carcinomas
Integrated Molecular Characterization of Uterine Carcinosarcoma - Rehan Akbani
Richard R. Barakat, MD: High-Risk Subtypes and Rare Uterine Cancers
Updates in Testing Endometrial Cancer Biomarkers